Market Overview

Tinnitus - 2018 Pipeline Insights featuring Knopp Biosciences, Auris Medical, Palau Pharma, Otonomy, Merz Pharma, and more - ResearchAndMarkets.com

Share:

The "Tinnitus
- Pipeline Insight, 2018"
drug pipelines has been added to ResearchAndMarkets.com's
offering.

This report offers comprehensive insights of the pipeline (under
development) therapeutics scenario and growth prospects across Tinnitus
development.

The report provides detailed coverage of the pipeline landscape for this
mechanism of action, equipped with data from multiple sources with
complete pipeline analysis by developmental stage, associated
indications, route of administration and molecule type

Pipeline Products covered across the following Developmental
Stages:

  • Clinical
  • Non-clinical
  • Inactive: Discontinued and/or Dormant

Scope

  • The report provides a snapshot of the pipeline development for Tinnitus
  • The report covers pipeline activity across the complete product
    development cycle i.e. clinical, pre-clinical and discovery stages for
    Tinnitus
  • The report provides pipeline product profiles which includes product
    description, developmental activities, licensors & collaborators and
    chemical information
  • Provides pipeline assessment by monotherapy and combination therapy
    products, stage of development, route of administration, and molecule
    type for Tinnitus
  • The report also covers the dormant and discontinued pipeline projects
    related to Tinnitus
Companies Featured
  • AudioCure Pharma GmbH
  • Auris Medical Holding AG
  • Knopp Biosciences LLC
  • Merz Pharma GmbH & Co. KgaA
  • Otonomy Inc.
  • SciFluor Life Sciences LLC
  • Palau Pharma
  • Sound Pharmaceuticals Inc.

Key Topics Covered

1. Report Introduction

2. Tinnitus Overview

3. Pipeline Therapeutics

  • An Overview of Pipeline Products for Tinnitus

4. Comparative Analysis

5. Products in Clinical Stage

5.1 Drug Name : Company Name

  • Product Description
  • Research and Development
  • Product Development Activities

6. Products in Pre-Clinical and Discovery Stage

6.1 Drug Name : Company Name

  • Product Description
  • Research and Development
  • Product Development Activities

7. Therapeutic Assessment

  • Assessment by Route of Administration
  • Assessment by Stage and Route of Administration
  • Assessment by Molecule Type
  • Assessment by Stage and Molecule Type

8. Inactive Products

8.1 Drug Name : Company Name

  • Product Description
  • Research and Development
  • Product Development Activities

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/z7qk8c/tinnitus_2018?w=4

View Comments and Join the Discussion!